Search results for "GI bleeding"
PPIs in patients receiving anticoagulation may not reduce upper GI events
There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
https://gastroenterology.acponline.org/archives/2019/05/24/3.htm
24 May 2019
Marketing authorized for new device that removes dead pancreatic tissue
The system is the first device indicated to treat patients with walled-off pancreatic necrosis resulting from complications of acute pancreatitis.
https://gastroenterology.acponline.org/archives/2021/01/22/7.htm
22 Jan 2021
Spotlight on postpolypectomy care
One recent study compared postpolypectomy surveillance with colonoscopy versus fecal immunochemical testing, while another assessed the rate of postpolypectomy complications in patients prescribed antithrombotic agents.
https://gastroenterology.acponline.org/archives/2018/12/28/5.htm
28 Dec 2018
Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease
Given the limitations of this large industry-funded trial, the only definitive conclusion one can draw is that patients on aspirin and rivaroxaban with low risk for bleeding may get a very small benefit from long-term proton-pump inhibitor therapy, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2019/10/25/8.htm
25 Oct 2019
Spotlight on Digestive Disease Week
Highlights from the conference, held this past week in San Diego, included new research and clinical tips on stopping Barrett's esophagus surveillance, diet and environmental risk factors in patients with inflammatory bowel disease, and new research on proton-pump inhibitors.
https://gastroenterology.acponline.org/archives/2019/05/24/5.htm
24 May 2019
GI safety profile varies among direct oral anticoagulants
Three propensity-matched cohorts of patients with nonvalvular atrial fibrillation who had incident exposure to dabigatran, rivaroxaban, or apixaban were compared.
https://gastroenterology.acponline.org/archives/2017/01/27/2.htm
27 Jan 2017
Spotlight on PPIs
Myocardial infarction risk appeared no greater with proton-pump inhibitors (PPIs) than with histamine H2 receptor antagonists in one recent study, while another study looked at the effect of a trainee-led program on inappropriate PPI infusions in hospitalized patients.
https://gastroenterology.acponline.org/archives/2017/11/28/5.htm
28 Nov 2017